Diagnostic usefulness of enzyme-linked immunospot assay for interferon-gamma for tuberculosis in cancer patients

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 11-12, 2010, Pages 851-856

  Lai, Chih Cheng ^a   Tan, Che Kim ^a   Lin, Sheng Hsiang ^b   Liu, Wen Lun ^a   Liao, Chun Hsing ^c   Wang, Cheng Yi ^d   Wang, Jen Yu ^d   Huang, Yu Tsung ^e   Lin, Hen I ^d   Hsueh, Po Ren ^e  

^a Chi Mei Medical Centre   (Taiwan)

^b Taipei County Hospital   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d CARDINAL TIEN HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; LUNG CANCER; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SOLID TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIOLOGICAL TECHNIQUES; CHILD; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 78549236894     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2010.498022     Document Type: Article

References (30)

1. Center for Disease Control, Taiwan. Statistics of communicable diseases and surveillance report. Taiwan, Republic of China: CDC; 2009. Available at: http://www.cdc.gov.tw/public/Data/9123117163971.pdf (accessed on 24-May-2010).
2. Yokoyama T, Sato R, Rikimaru T, Hirai R, Aizawa H. Tuberculosis associated with gastrectomy. J Infect Chemother 2004;10:299-302.
3. Kleinschmidt I, Churchyard G. Variation in incidences of tuberculosis in subgroups of South African gold miners. Occup Environ Med 1997;54:636-41.
4. Corbett EL, Churchyard GJ, Clayton TC, Williams BG, Mulder D, Hayes RJ, De Cock KM. HIV infection and silicosis: the impact of two potent risk factors on the incidences of mycobacterial diseases in South African miners. AIDS 2000;14:2759-68.
5. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systemic review of 13 observational studies. PLoS Med 2008;5:e152.
6. Kim HR, Hwang SS, Ro YK, Jeon CH, Ha DY, Park SJ, et al. Solid-organ malignancy as a risk factor for tuberculosis. Respirology 2008;13:413-9.
7. Khan B, Ahmed P, Ullah K, Hussain CA, Hussain I, Raza S. Frequency of tuberculosis in hematologic malignancies and stem cell transplant recipients. J Coll Physicians Surg Pak 2005;15:30-3.
8. Feld R, Bodey GP, Groschel D. Mycobacteriosis in patients with malignant disease. A review of 201 cases. Cancer 1974;33:850-8.
9. Hill PC, Brookes RH, Fox A, Fieldin K, Jeffries DJ, Jackson- Sillah D, et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis 2004;38:966-73.
10. Nicol MP, Pienaar D, Wood K, Eley B, Wilkinson RJ, Henderson H, et al. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture fi ltrate protein 10, and purifi ed protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis 2005;40:1301-8.
11. Hill PC, Fox A, Jeffries DJ, Jackson-Sillah D, Lugos MD, Owiafe PK, et al. Quantitative T cell assay refl ects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin Infect Dis 2005;40:273-8.
12. Wang JY, Chou CH, Lee LN, Hsu HL, Jan IS, Hsueh PR, et al. Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon- ã . Emerg Infect Dis 2007;13:553-8.
13. Lai CC, Tan CK, Huang YT, Chou CH, Hung CC, Yang PC, et al. Extensively-drug resistant Mycobacterium tuberculosis during a trend of declining drug resistance between 2000 and 2006 at a medical center in Taiwan. Clin Infect Dis 2008;47:e57 - 63.
14. Idigoras P, Beristain X, Iturzaeta A, Vicente D, Perez-Trallero E. Comparison of the automated nonradiometric Bactec MGIT 960 system with Lowenstein - Jensen, Coletsos, and Middlebrook 7H11 solid media for recovery of mycobacteria. Eur J Clin Microbiol Infect Dis 2000;9:350-4.
15. Kang YA, Lee HW, Hwang SS, UM SW, Han SK, Shim YS, Yim JJ. Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007;132:959-65.
16. Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specifi c T cells. Am J Respir Crit Care Med 2001;163:824-8.
17. Tan CK, Hung CC, Lai CC, Liao CH, Chou CH, Huan YT, Hsueh PR. Diagnosis of active tuberculosis by enzyme-linked immunospot assay for interferon- ã in HIV-infected patients. J Acquir Immune Defi c Syndr 2010;54:546-7.
18. Tan CK, Lai CC, Liao CH, Chou CH, Hsu HL, Huan YT, Hsueh PR. Rapid diagnosis of active pulmonary tuberculosis in the elderly by enzyme-linked immunospot assay for interferon- gamma. J Am Geriat Soc 2009;57:2361-2.
19. Lai CC, Tan CK, Liao CH, Chou CH, Huang YT, Hsueh PR. Diagnosis of pulmonary tuberculosis among dialysis patients by enzyme-linked immunospot assay for interferon- Ã . Nephrol Dial Transplant 2009;24:2605-6.
20. Lee LN, Chou CH, Wang JY, Hsu HL, Tsai TH, Jan IS, et al. Enzyme-linked immunospot assay for interferongamma in the diagnosis of tuberculous pleurisy. Clin Microbiol Infect 2009;15:173-9.
21. Lai CC, Liao CH, Tan CK, Chou CH, Huang YT, Hsueh PR. Diagnosis of peripheral tuberculous lymphadenitis by enzyme-linked immunospot assay for interferon-gamma. Am J Med 2009;122:e3.
22. Lai CC, Lee TC, Hsiao CH, Liao CH, Chou CH, Tan CK, et al. Differential diagnosis of Crohn s disease and intestinal tuberculous by enzyme-linked immunospot assay for interferon- ã . Am J Gastroenterol 2009;104:2121-2.
23. Kim SH, Song KH, Choi SJ, Kim HB, Kim NJ, Oh MD, Choe KW. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients. Am J Med 2009;122:189-95.
24. Rolston KV, Rodriguez S, Dholakia N, Whimbey E, Raad I. Pulmonary infection mimicking cancer: a retrospective, three-year review. Support Care Cancer 1997;5:90-3.
25. Rybacka-Chabros B, Madziuk S, Berger-Lukasiewicz A, Danko-Mronzinska M, Milanowski J. The coexistence of tuberculosis infection and lung cancer in patients treated in pulmonary department of Medical Academy in Lublin during last ten years (1990 - 2000). Folia Histochem Cytobiol 2001;39(Suppl 2):73-4.
26. Inadome Y, Ilkezawa T, Oyasu R, Noguchi M. Malignant lymphoma of bronchus-associated lymphoid tissue (BALT) coexistent with pulmonary tuberculosis. Pathol Int 2001; 51:807-11.
27. Pai M, Riley LW, Colford JM. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004;4:761-6.
28. Arend SM, van Meijgaarden KE, de Boer K, de Palou EC, van Soolingen D, Ottenhoff TH, van Dissel JT. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture fi ltrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J Infect Dis 2002;186:1797-807.
29. Lai CC, Tan CK, Chou CH, Hsu HL, Liao CH, Huang YT, et al. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000 - 2008. Emerg Infect Dis 2010;16:294-6.
30. Park SY, Jeon K, Um SW, Kwon OJ, Kang ES, Koh WJ. Clinical utility of the QuantiFERON-TB Gold In-Tube test for the diagnosis of active pulmonary tuberculosis. Scand J Infect Dis 2009;41:818-22.